{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:48:10Z","timestamp":1793404090512,"version":"4.5.0"},"reference-count":203,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune blistering disorders (AIBDs) are a heterogeneous group of approximately a dozen entities comprising pemphigus and pemphigoid disorders and dermatitis herpetiformis. The exact diagnosis of AIBDs is critical for both prognosis and treatment and is based on the clinical appearance combined with the detection of tissue-bound and circulating autoantibodies. While blisters and erosions on the skin and\/or inspectable mucosal surfaces are typical, lesions may be highly variable with erythematous, urticarial, prurigo-like, or eczematous manifestations. While direct immunofluorescence microscopy (IFM) of a perilesional biopsy is still the diagnostic gold standard, the molecular identification of the major target antigens opened novel therapeutic avenues. At present, most AIBDs can be diagnosed by the detection of autoantigen-specific serum antibodies by enzyme-linked immunosorbent assay (ELISA) or indirect IFM when the clinical picture is known. This is achieved by easily available and highly specific and sensitive assays employing recombinant immunodominant fragments of the major target antigens, i.e., desmoglein 1 (for pemphigus foliaceus), desmoglein 3 (for pemphigus vulgaris), envoplakin (for paraneoplastic pemphigus), BP180\/type XVII collagen (for bullous pemphigoid, pemphigoid gestationis, and mucous membrane pemphigoid), laminin 332 (for mucous membrane pemphigoid), laminin \u03b24 (for anti-p200 pemphigoid), type VII collagen (for epidermolysis bullosa acquisita and mucous membrane pemphigoid), and transglutaminase 3 (for dermatitis herpetiformis). Indirect IFM on tissue substrates and in-house ELISA and immunoblot tests are required to detect autoantibodies in some AIBD patients including those with linear IgA disease. Here, a straightforward modern approach to diagnosing AIBDs is presented including diagnostic criteria according to national and international guidelines supplemented by long-term in-house expertise.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1363032","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:23:44Z","timestamp":1718133824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":64,"title":["State-of-the-art diagnosis of autoimmune blistering diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Nina","family":"van Beek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike M.","family":"Holtsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Atefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Olbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie J.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Pruessmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3238\/aerztebl.m.2021.0136","article-title":"Bullous autoimmune dermatoses-clinical features, diagnostic evaluation, and treatment options","volume":"118","author":"Beek","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus.","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome","volume":"355","author":"Stanley","year":"2006","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01290","article-title":"Dermatitis herpetiformis: novel perspectives","volume":"10","author":"Antiga","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00584-2","article-title":"Dermatitis herpetiformis: an update on diagnosis and management","volume":"22","author":"Reunala","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges."},{"key":"B10","doi-asserted-by":"publisher","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"Bmj."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.2009.161.issue-4","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archderm.131.1.48","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Bullous Dis French Study Group Arch Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12026-017-8975-2","article-title":"Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(74)90365-X","article-title":"Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion","volume":"38","author":"Pisanti","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1016\/j.xjidi.2021.100004","article-title":"Epidemiology of pemphigus","volume":"1","author":"Kridin","year":"2021","journal-title":"JID Innov"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16467","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases among pediatric patients in Germany","author":"Hubner","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)","volume":"34","author":"Joly","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14097","article-title":"S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid: 2019 update","volume":"18","author":"Schmidt","year":"2020","journal-title":"J Dtsch Dermatol Ges."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17202","article-title":"A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid","author":"Goletz","year":"2018","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17183","article-title":"S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"35","author":"Gorog","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jid.2022.11.001","article-title":"Obituary for Professor Detlef Zillikens- creator of a powerhouse of dermatology research at the University of L\u00fcbeck, Germany","volume":"143","author":"Schmidt","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s001050051124","article-title":"[Pemphigus. Loss of desmosomal cell-cell contact]","volume":"51","author":"Schmidt","year":"2000","journal-title":"Hautarzt."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.11.059","article-title":"IgA pemphigus: A systematic review","volume":"82","author":"Kridin","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18931","article-title":"S2k guidelines on the management of paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"37","author":"Antiga","year":"2023","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1610-0387.2010.07380_supp.x","article-title":"Clinical and immunopathological spectrum of paraneoplastic pemphigus","volume":"8","author":"Zimmermann","year":"2010","journal-title":"J Dtsch Dermatol Ges."},{"key":"B31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/08916934.2011.606447","article-title":"Pemphigoid diseases: pathogenesis, diagnosis, and treatment","volume":"45","author":"Kasperkiewicz","year":"2012","journal-title":"Autoimmunity."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.2012.167.issue-5","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort","volume":"167","author":"della Torre","year":"2012","journal-title":"Br J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.det.2011.03.010","article-title":"Clinical features and practical diagnosis of bullous pemphigoid","volume":"29","author":"Schmidt","year":"2011","journal-title":"Dermatol Clin"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14494","article-title":"Immunological features and factors associated with mucocutaneous bullous pemphigoid - a retrospective cohort study","volume":"19","author":"Stander","year":"2021","journal-title":"J Dtsch Dermatol Ges."},{"key":"B35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13023-014-0136-2","article-title":"Gestational pemphigoid","volume":"9","author":"Huilaja","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00105-017-4089-y","article-title":"[Mucous membrane pemphigoid]","volume":"69","author":"Holtsche","year":"2018","journal-title":"Hautarzt."},{"key":"B38","doi-asserted-by":"publisher","first-page":"103036","DOI":"10.1016\/j.autrev.2022.103036","article-title":"Mucous membrane pemphigoid","volume":"21","author":"Du","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4773","article-title":"Evaluation of site- and autoantigen-specific characteristics of mucous membrane pemphigoid","volume":"158","author":"van Beek","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1001\/jamadermatol.2022.5829","article-title":"Characteristics associated with refractory course, blindness, and treatment strategy-related outcomes in patients with mucous membrane pemphigoid","volume":"159","author":"Kridin","year":"2023","journal-title":"JAMA Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17397","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I","volume":"35","author":"Rashid","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16045","article-title":"Brunsting-Perry pemphigoid: a systematic review","volume":"61","author":"Aromolo","year":"2022","journal-title":"Int J Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-019-4376-x","article-title":"[Anti-p200 pemphigoid]","volume":"70","author":"Holtsche","year":"2019","journal-title":"Hautarzt."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.02.036","article-title":"Anti-p200 pemphigoid","volume":"71","author":"Goletz","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02466","article-title":"Anti-p200 pemphigoid: A systematic review","volume":"10","author":"Kridin","year":"2019","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/jcm12010328","article-title":"The intriguing links between psoriasis and bullous pemphigoid","volume":"12","author":"Maronese","year":"2022","journal-title":"J Clin Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/JID.2015.356","article-title":"Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options","volume":"136","author":"Kasperkiewicz","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.06.002","article-title":"Bullous systemic lupus erythematosus","volume":"29","author":"Sebaratnam","year":"2011","journal-title":"Dermatol Clin"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01389","article-title":"Lichen planus pemphigoides: from lichenoid inflammation to autoantibody-mediated blistering","volume":"10","author":"Hubner","year":"2019","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0290","article-title":"Clinical and serological characterization of orf-induced immunobullous disease","volume":"158","author":"Yilmaz","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B51","article-title":"Immunobullous disorders","volume-title":"Rook\u2019s Textbook of Dermatology, part 3, chapter 50, 10th edition","author":"Schmidt","year":"2024"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14973","article-title":"Immunoglobulin M mucous membrane pemphigoid","volume":"21","author":"Yilmaz","year":"2023","journal-title":"J Dtsch Dermatol Ges."},{"key":"B53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1610-0387.2009.07292.x","article-title":"Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring","volume":"8","author":"Rose","year":"2010","journal-title":"J Dtsch Dermatol Ges."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.2011.165.issue-1","article-title":"The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy","volume":"165","author":"Buijsrogge","year":"2011","journal-title":"Br J Dermatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.2013.169.issue-1","article-title":"Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14408","article-title":"Laboratory diagnosis of pemphigus: direct immunofluorescence remains the gold standard","volume":"175","author":"Giurdanella","year":"2016","journal-title":"Br J Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4390","article-title":"Assessment of diagnostic strategy for early recognition of bullous and nonbullous variants of pemphigoid","volume":"155","author":"Meijer","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"Sardy","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06006.x","article-title":"U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases","volume":"151","author":"Vodegel","year":"2004","journal-title":"Br J Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.11.029","article-title":"Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases","volume":"78","author":"Meijer","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10474.x","article-title":"Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients","volume":"165","author":"Terra","year":"2011","journal-title":"Br J Dermatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.2013.169.issue-1","article-title":"The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2017.01.011","article-title":"Immunofluorescence of autoimmune bullous diseases","volume":"10","author":"Diercks","year":"2017","journal-title":"Surg Pathol Clin"},{"key":"B64","doi-asserted-by":"publisher","first-page":"adv00410","DOI":"10.2340\/00015555-3748","article-title":"Diagnostic value and practicability of serration pattern analysis by direct immunofluorescence microscopy in pemphigoid diseases","volume":"101","author":"Holtsche","year":"2021","journal-title":"Acta Derm Venereol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jaad.2017.05.016","article-title":"Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid","volume":"77","author":"Shimanovich","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18032","article-title":"The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris","volume":"182","author":"Carey","year":"2020","journal-title":"Br J Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14905","article-title":"S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid","volume":"20","author":"Hofmann","year":"2022","journal-title":"J Dtsch Dermatol Ges."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.08.007","article-title":"Modern diagnosis of autoimmune blistering skin diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9781118441213.rtd0051","article-title":"Immunobullous diseases","volume-title":"Rook\u2019s Textbook of Dermatology, part 3, chapter 50, 9th edition","author":"Schmidt","year":"2016"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1118846","article-title":"Potential contribution of anti-p200 autoantibodies to mucosal lesions in anti-p200 pemphigoid","volume":"14","author":"Gao","year":"2023","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2133.1988.tb01747.x","article-title":"The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid","volume":"118","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12259692","article-title":"Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin","volume":"82","author":"Gammon","year":"1984","journal-title":"J Invest Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70027-7","article-title":"Herpes gestationis: clinical and histologic features of twenty-eight cases","volume":"8","author":"Shornick","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00622.x","article-title":"IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis","volume":"113","author":"Chimanovitch","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B76","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Blocker","year":"2012","journal-title":"Br J Dermatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"adv00420","DOI":"10.2340\/00015555-3774","article-title":"Diagnosis of epidermolysis bullosa acquisita: multicentre comparison of different assays for serum anti-type VII collagen reactivity","volume":"101","author":"Holtsche","year":"2021","journal-title":"Acta Derm Venereol."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01069.x","article-title":"Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients","volume":"19","author":"Schmidt","year":"2010","journal-title":"Exp Dermatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jaad.2016.11.002","article-title":"Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases","volume":"76","author":"van Beek","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin Chim Acta"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"B86","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2012","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jaad.2018.02.021","article-title":"Diagnosis and management of pemphigus: Recommendations of an international panel of experts","volume":"82","author":"Murrell","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.02.025","article-title":"Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides","volume":"66","author":"Kasperkiewicz","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-7-49","article-title":"Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy","volume":"7","author":"van Beek","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B90","article-title":"The value of the BIOCHIP mosaic-based indirect immunofluorescence technique in the diagnosis of pemphigus and bullous pemphigoid in turkish patients","volume":"25","author":"Ozkesici","year":"2017","journal-title":"Acta Dermatovenerol Croat."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2013.12.012","article-title":"The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris","volume":"116","author":"Russo","year":"2014","journal-title":"Acta Histochem"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2460","article-title":"Value of BIOCHIP technology in the serological diagnosis of pemphigoid gestationis","volume":"97","author":"Sadik","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000339776","article-title":"Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases","volume":"225","author":"Tampoia","year":"2012","journal-title":"Dermatology."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2017.10.001","article-title":"New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature","volume":"4","author":"Xuan","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15770","article-title":"Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceous","volume":"34","author":"Yang","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"237802","DOI":"10.5402\/2012\/237802","article-title":"Biochip technology for the serological diagnosis of bullous pemphigoid","volume":"2012","author":"Zarian","year":"2012","journal-title":"ISRN Dermatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1111172","article-title":"Computer-aided classification of indirect immunofluorescence patterns on esophagus and split skin for the detection of autoimmune dermatoses","volume":"14","author":"Hocke","year":"2023","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-016-1632-0","article-title":"The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita","volume":"308","author":"Marzano","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.005","article-title":"Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA)","volume":"74","author":"Seta","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13409","article-title":"Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus","volume":"26","author":"Mindorf","year":"2017","journal-title":"Exp Dermatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.12.032","article-title":"Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita","volume":"68","author":"Komorowski","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773720","article-title":"Comparison of two diagnostic assays for anti-laminin 332 mucous membrane pemphigoid","volume":"12","author":"Goletz","year":"2021","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.049","article-title":"Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology","volume":"83","author":"van Beek","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.2016.175.issue-4","article-title":"Clinical and immunological features and outcome of anti-p200 pemphigoid","volume":"175","author":"Commin","year":"2016","journal-title":"Br J Dermatol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/bjd.2010.164.issue-1","article-title":"Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid","volume":"164","author":"Groth","year":"2011","journal-title":"Br J Dermatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12349283","article-title":"A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone","volume":"106","author":"Zillikens","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809230106","article-title":"Anti-laminin gamma-1 pemphigoid","volume":"106","author":"Dainichi","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16513","article-title":"A Chinese case of concurrent anti-laminin gamma1 pemphigoid and anti-laminin 332-type mucous membrane pemphigoid","volume":"50","author":"Liu","year":"2023","journal-title":"J Dermatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.903174","article-title":"Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin gamma1 Antibodies and IgA Anti-Laminin alpha5 Antibodies","volume":"13","author":"Kuang","year":"2022","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13107","article-title":"A case of concurrent antilaminin gamma1 pemphigoid and antilaminin-332-type mucous membrane pemphigoid","volume":"171","author":"Li","year":"2014","journal-title":"Br J Dermatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.06.004","article-title":"Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid","volume":"51","author":"Lazarova","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12345782","article-title":"LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells","volume":"106","author":"Marinkovich","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.948108","article-title":"Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders","volume":"13","author":"Opelka","year":"2022","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.0762","article-title":"Evaluation and comparison of clinical and laboratory characterstics of patients with IgA epidermolysis bullosa acquisita, linear IgA bullous dermatosis, and IgG epidermolysis bullosa acquisita","volume":"157","author":"Becker","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00808.x","article-title":"Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-6-31","article-title":"Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases","volume":"6","author":"Csorba","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13023-018-0855-x","article-title":"Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid","volume":"13","author":"Chiorean","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Invest."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18129","article-title":"Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases","volume":"182","author":"Giurdanella","year":"2020","journal-title":"Br J Dermatol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012250","article-title":"The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human","volume":"5","author":"Schepens","year":"2010","journal-title":"PloS One"},{"key":"B123","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin is a paraneoplastic pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B124","first-page":"77","article-title":"Paraneoplastic pemphigus","volume":"12","author":"Anhalt","year":"1997","journal-title":"Adv Dermatol."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040703","article-title":"Classification and antigen molecules of autoimmune bullous diseases","volume":"13","author":"Hashimoto","year":"2023","journal-title":"Biomolecules"},{"key":"B127","article-title":"Integrin beta4 is a major target antigen in pure ocular mucous membrane pemphigoid","volume":"26","author":"Li","year":"2016","journal-title":"Eur J Dermatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18617","article-title":"Anti-beta4 integrin autoantibodies in patients with mucous membrane pemphigoid: A retrospective analysis from a tertiary centre in Italy","volume":"37","author":"Maglie","year":"2023","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","article-title":"A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid","volume":"346","author":"Messingham","year":"2009","journal-title":"J Immunol Methods"},{"key":"B131","article-title":"Clinical and immunological studies of 332 Japanese patients tentatively diagnosed as anti-BP180-type mucous membrane pemphigoid: A novel BP180 C-terminal domain enzyme-linked immunosorbent assay","volume":"96","author":"Yasukochi","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14410","article-title":"Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris","volume":"175","author":"Ali","year":"2016","journal-title":"Br J Dermatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14351","article-title":"Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid","volume":"174","author":"Ali","year":"2016","journal-title":"Br J Dermatol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Med (Baltimore)."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/s00292-020-00795-8","article-title":"[Modern diagnostics of autoimmune bullous diseases]","volume":"41","author":"van Beek","year":"2020","journal-title":"Pathologe."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17303","article-title":"The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid","volume":"35","author":"Stander","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1590\/abd1806-4841.2019940208","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology","volume":"94","author":"Vale","year":"2019","journal-title":"Bras Dermatol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(91)90020-L","article-title":"Dermatitis herpetiformis: histopathologic findings","volume":"9","author":"Imber","year":"1991","journal-title":"Clin Dermatol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.02.012","article-title":"Histopathology of anti-laminin 5 mucous membrane pemphigoid","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e31803326e6","article-title":"Histopathology of anti-p200 pemphigoid","volume":"29","author":"Rose","year":"2007","journal-title":"Am J Dermatopathol."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.2016.175.issue-5","article-title":"Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid","volume":"175","author":"Glauser","year":"2016","journal-title":"Br J Dermatol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2009.01450.x","article-title":"C3d immunohistochemistry on formalin-fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin","volume":"37","author":"Pfaltz","year":"2010","journal-title":"J Cutan Pathol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12732","article-title":"Immunohistochemical diagnosis of mucous membrane pemphigoid","volume":"47","author":"Shimanovich","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000000333","article-title":"Application of C4d immunohistochemistry on routinely processed tissue sections for the diagnosis of autoimmune bullous dermatoses","volume":"38","author":"Villani","year":"2016","journal-title":"Am J Dermatopathol."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001817","article-title":"Immunoglobulin and complement immunohistochemistry on paraffin sections in autoimmune bullous diseases: A systematic review and meta-analysis","volume":"43","author":"Kasperkiewicz","year":"2021","journal-title":"Am J Dermatopathol."},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12612","article-title":"S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid","volume":"13","author":"Schmidt","year":"2015","journal-title":"J Dtsch Dermatol Ges."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.049","article-title":"Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP(TM) technology","volume":"83","author":"van Beek","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13813","article-title":"Nomenclature for diseases with IgA antikeratinocyte cell surface autoantibodies","volume":"173","author":"Hashimoto","year":"2015","journal-title":"Br J Dermatol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.01.014","article-title":"IgA pemphigus","volume":"29","author":"Tsuruta","year":"2011","journal-title":"Clin Dermatol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.017","article-title":"Immunoglobulin M pemphigoid","volume":"85","author":"Boch","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.1036","article-title":"Assessment of diagnostic strategy for mucous membrane pemphigoid","volume":"157","author":"Rashid","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0923-1811(97)00067-4","article-title":"Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid","volume":"17","author":"Murakami","year":"1998","journal-title":"J Dermatol Sci"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2002.01016.x","article-title":"Pemphigoid gestationis: new insights into the pathogenesis lead to novel diagnostic tools","volume":"109","author":"Shimanovich","year":"2002","journal-title":"BJOG."},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2016.02.010","article-title":"Pemphigoid gestationis: Toward a better understanding of the etiopathogenesis","volume":"34","author":"Sadik","year":"2016","journal-title":"Clin Dermatol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.6.705","article-title":"Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy","volume":"141","author":"Powell","year":"2005","journal-title":"Arch Dermatol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000115506.76104.ad","article-title":"Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis","volume":"103","author":"Sitaru","year":"2004","journal-title":"Obstet Gynecol."},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03824.x","article-title":"Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis","volume":"47","author":"Barnadas","year":"2008","journal-title":"Int J Dermatol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0190-9622(88)70236-4","article-title":"Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap","volume":"19","author":"Wojnarowska","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-019-4377-9","article-title":"[Linear IgA bullous dermatosis]","volume":"70","author":"Juratli","year":"2019","journal-title":"Hautarzt."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.0762","article-title":"Evaluation and comparison of clinical and iLaboratory characteristics of patients with IgA epidermolysis bullosa acquisita, linear IgA bullous dermatosis, and IgG epidermolysis bullosa acquisita","volume":"157","author":"Becker","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12261260","article-title":"Immunofluorescence studies in the diagnosis of dermatitis herpetiformis and its differentiation from bullous pemphigoid","volume":"56","author":"Chorzelski","year":"1971","journal-title":"J Invest Dermatol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamadermatol.2016.1099","article-title":"Laboratory diagnosis and clinical profile of anti-p200 pemphigoid","volume":"152","author":"Meijer","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2009.00793.x","article-title":"From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid","volume":"37","author":"Dainichi","year":"2010","journal-title":"J Dermatol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.01.001","article-title":"An attempt to develop mouse model for anti-laminin gamma1 pemphigoid","volume":"70","author":"Koga","year":"2013","journal-title":"J Dermatol Sci"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041769","article-title":"Pathogenicity of autoantibodies in anti-p200 pemphigoid","volume":"7","author":"Vafia","year":"2012","journal-title":"PloS One"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.11.014","article-title":"Laminin beta4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid","volume":"90","author":"Goletz","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"ljae136","DOI":"10.1093\/bjd\/ljae136","article-title":"Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on recombinant laminin \u03b24","volume":"28","author":"Goletz","year":"2024","journal-title":"Br J Dermatol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/bjd.16138","article-title":"International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita","volume":"179","author":"Prost-Squarcioni","year":"2018","journal-title":"Br J Dermatol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12461226","article-title":"Immunoelectron microscopy in subepidermal autoimmune bullous diseases: a prospective study of IgG and C3 bound in vivo in 32 patients","volume":"89","author":"Prost","year":"1987","journal-title":"J Invest Dermatol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb06550.x","article-title":"Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients","volume":"102","author":"Nieboer","year":"1980","journal-title":"Br J Dermatol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.132.2.151","article-title":"Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping","volume":"132","author":"De Jong","year":"1996","journal-title":"Arch Dermatol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.8.1007","article-title":"A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy","volume":"139","author":"Wozniak","year":"2003","journal-title":"Arch Dermatol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00296","article-title":"Diagnosis of autoimmune blistering diseases","volume":"5","author":"Witte","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(98)83248-9","article-title":"The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease","volume":"8","author":"Vodegel","year":"1998","journal-title":"Eur J Dermatol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04617.x","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","article-title":"Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita","volume":"108","author":"Chen","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12129","article-title":"Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients","volume":"28","author":"Calabresi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/1744666X.2016.1196136","article-title":"Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University","volume":"12","author":"Hashimoto","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B181","article-title":"A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen","volume":"77","author":"Tanaka","year":"1997","journal-title":"Lab Invest."},{"key":"B182","volume-title":"Bullous Systemic Lupus Erythematosus","author":"Odonwodo","year":"2023"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70210-0","article-title":"Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature","volume":"9","author":"Camisa","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/1523-1747.ep12355583","article-title":"Indirect immunofluorescence in vesiculobullous eruption of systemic lupus erythematosus","volume":"86","author":"Camisa","year":"1986","journal-title":"J Invest Dermatol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"28S","DOI":"10.1111\/1523-1747.ep12355210","article-title":"Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder","volume":"100","author":"Gammon","year":"1993","journal-title":"J Invest Dermatol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2003.12.020","article-title":"Bullous systemic lupus erythematosus","volume":"22","author":"Vassileva","year":"2004","journal-title":"Clin Dermatol."},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.5.569","article-title":"Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen","volume":"135","author":"Chan","year":"1999","journal-title":"Arch Dermatol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200208000-00003","article-title":"Characterization of a subgroup of patients with dermatitis herpetiformis with nonclassical histologic features","volume":"24","author":"Warren","year":"2002","journal-title":"Am J Dermatopathol."},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181a81384","article-title":"Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA\/IgG serum antibodies to tissue transglutaminase","volume":"50","author":"Dahlbom","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2000.4983","article-title":"Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis","volume":"98","author":"Kumar","year":"2001","journal-title":"Clin Immunol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08629.x","article-title":"Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis","volume":"159","author":"Hull","year":"2008","journal-title":"Br J Dermatol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020467","article-title":"Intestinal TG3- and TG2-specific plasma cell responses in dermatitis herpetiformis patients undergoing a gluten challenge","volume":"12","author":"Sankari","year":"2020","journal-title":"Nutrients"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70253-7","article-title":"Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease","volume":"41","author":"Rose","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"B194","doi-asserted-by":"crossref","DOI":"10.1093\/ced\/llad319","article-title":"Serum reactivity in dermatitis herpetiformis: an international multicentre study","volume":"49","author":"Boch","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(03)00027-2","article-title":"HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease","volume":"64","author":"Karell","year":"2003","journal-title":"Hum Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-020-0700-2","article-title":"Improved HLA-based prediction of coeliac disease identifies two novel genetic interactions","volume":"28","author":"Erlichster","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1177\/2050640614559263","article-title":"The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis","volume":"3","author":"Ciacci","year":"2015","journal-title":"United Eur Gastroenterol J"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1977.tb14122.x","article-title":"Gluten-free diet in dermatitis herpetiformis. I. Clinical response of skin lesions in 81 patients","volume":"97","author":"Reunala","year":"1977","journal-title":"Br J Dermatol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)91539-0","article-title":"Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal","volume":"1","author":"Fry","year":"1973","journal-title":"Lancet."},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.03.1150","article-title":"Gluten challenge induces skin and small bowel relapse in long-term gluten-free diet-treated dermatitis herpetiformis","volume":"139","author":"Mansikka","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb07250.x","article-title":"The potassium iodide patch test in the dermatitis herpetiformis in relation to treatment with a gluten-free diet and dapsone","volume":"103","author":"Haffenden","year":"1980","journal-title":"Br J Dermatol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591971","article-title":"Milestones in personalized medicine in pemphigus and pemphigoid","volume":"11","author":"Bieber","year":"2020","journal-title":"Front Immunol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15046","article-title":"Autoimmune bullous dermatoses","volume":"21","author":"Holtsche","year":"2023","journal-title":"J Dtsch Dermatol Ges."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1363032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:23:56Z","timestamp":1718133836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1363032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":203,"alternative-id":["10.3389\/fimmu.2024.1363032"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1363032","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"article-number":"1363032"}}